Oral Azithromycin Versus Doxycycline in Posterior Blepharitis
Posterior Blepharitis
Bottom Line
View on ClinicalTrials.gov: NCT01783860 ↗Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Azithromycin (Drug); Doxycycline (Drug)
- Age
- Pediatric, Adult, Older Adult · 13+ yrs
- Sex
- All
- Sponsor
- Tehran University of Medical Sciences
- Primary completion
- Jul 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change of Blepharitis Symptoms Score |
1.8; 2.8 | 0.03 sig |
| PRIMARY Change of Symptoms and Signs Scores (Difference Between Total Score of First Time and 61 Days Later), Total Severity Score |
6.5; 8.6 | 0.007 sig |
| SECONDARY Main Ocular Signs |
4.7; 5.7 | 0.01 sig |
Summary
Eligibility Criteria
Inclusion Criteria
Patients were diagnosed with posterior blepharitis if they scored at least one in two symptoms (based on a subjective grading scale) and two signs (based on an objective grading scale) of posterior blepharitis according to study criteria
Exclusion Criteria
Patients were excluded if they had the following criteria: age< 12 years old,history of previous ocular or lacrimal surgery,previous usage of contact lenses,any history of ocular allergy,history of systemic diseases with ocular involvement (except rosacea), history of usage of topical or systemic antibiotic in the last month, pregnancy or lactating mothers, liver failure and any history of sensitivity to cyclines
Data sourced from ClinicalTrials.gov (NCT01783860). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.